Analyst Ratings for Can-Fite BioPharma (CANF)
CANF Rating Summary
CANF Price Target Summary
- Highest: $8.00 (H.C. Wainwright)
- Lowest: $7.00 (D. Boral Capital)
- Average: $7.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.50 (+120.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$7.50 (+120.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2026 | D. Boral Capital | Jason Kolbert | Upgrade | Buy (Hold) |
7.00 (N/A) |
3.39 (3.40) |
0.29% | Details |
| 11/4/2025 | H.C. Wainwright » Updated 7/2/2026 |
Swayampakula Ramakanth | New Coverage | Buy (N/A) |
8.00 (5.00) |
0.41 (3.40) |
729.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
